Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1964 1
1965 1
1970 1
1978 1
1984 2
1985 2
1986 1
1987 3
1991 3
1992 11
1993 9
1994 13
1995 4
1996 5
1997 5
1998 1
2001 1
2002 1
2003 2
2004 4
2005 6
2006 4
2007 2
2008 4
2009 2
2010 5
2011 8
2012 6
2013 7
2014 6
2015 5
2016 4
2017 1
2018 2
2019 5
2020 2
2021 5
2022 2
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

139 results

Results by year

Filters applied: . Clear all
Page 1
Abiraterone acetate plus prednisone versus placebo plus prednisone in chemotherapy-naive men with metastatic castration-resistant prostate cancer (COU-AA-302): final overall survival analysis of a randomised, double-blind, placebo-controlled phase 3 study.
Ryan CJ, Smith MR, Fizazi K, Saad F, Mulders PF, Sternberg CN, Miller K, Logothetis CJ, Shore ND, Small EJ, Carles J, Flaig TW, Taplin ME, Higano CS, de Souza P, de Bono JS, Griffin TW, De Porre P, Yu MK, Park YC, Li J, Kheoh T, Naini V, Molina A, Rathkopf DE; COU-AA-302 Investigators. Ryan CJ, et al. Lancet Oncol. 2015 Feb;16(2):152-60. doi: 10.1016/S1470-2045(14)71205-7. Epub 2015 Jan 16. Lancet Oncol. 2015. PMID: 25601341 Clinical Trial.
Abiraterone in metastatic prostate cancer without previous chemotherapy.
Ryan CJ, Smith MR, de Bono JS, Molina A, Logothetis CJ, de Souza P, Fizazi K, Mainwaring P, Piulats JM, Ng S, Carles J, Mulders PF, Basch E, Small EJ, Saad F, Schrijvers D, Van Poppel H, Mukherjee SD, Suttmann H, Gerritsen WR, Flaig TW, George DJ, Yu EY, Efstathiou E, Pantuck A, Winquist E, Higano CS, Taplin ME, Park Y, Kheoh T, Griffin T, Scher HI, Rathkopf DE; COU-AA-302 Investigators. Ryan CJ, et al. N Engl J Med. 2013 Jan 10;368(2):138-48. doi: 10.1056/NEJMoa1209096. Epub 2012 Dec 10. N Engl J Med. 2013. PMID: 23228172 Free PMC article. Clinical Trial.
Niraparib in patients with metastatic castration-resistant prostate cancer and DNA repair gene defects (GALAHAD): a multicentre, open-label, phase 2 trial.
Smith MR, Scher HI, Sandhu S, Efstathiou E, Lara PN Jr, Yu EY, George DJ, Chi KN, Saad F, Ståhl O, Olmos D, Danila DC, Mason GE, Espina BM, Zhao X, Urtishak KA, Francis P, Lopez-Gitlitz A, Fizazi K; GALAHAD investigators. Smith MR, et al. Lancet Oncol. 2022 Mar;23(3):362-373. doi: 10.1016/S1470-2045(21)00757-9. Epub 2022 Feb 4. Lancet Oncol. 2022. PMID: 35131040 Free PMC article. Clinical Trial.
Nuclear Medicine Scans in Total Joint Replacement.
Pinski JM, Chen AF, Estok DM, Kavolus JJ. Pinski JM, et al. J Bone Joint Surg Am. 2021 Feb 17;103(4):359-372. doi: 10.2106/JBJS.20.00301. J Bone Joint Surg Am. 2021. PMID: 33369983 Review.
Diet and prostate cancer risk reduction.
Cheung E, Wadhera P, Dorff T, Pinski J. Cheung E, et al. Among authors: pinski j. Expert Rev Anticancer Ther. 2008 Jan;8(1):43-50. doi: 10.1586/14737140.8.1.43. Expert Rev Anticancer Ther. 2008. PMID: 18095882 Review.
Liposuction for lipomas.
Rubenstein R, Roenigk HH Jr, Garden JM, Goldberg NS, Pinski JB. Rubenstein R, et al. Among authors: pinski jb. J Dermatol Surg Oncol. 1985 Nov;11(11):1070-4. doi: 10.1111/j.1524-4725.1985.tb01395.x. J Dermatol Surg Oncol. 1985. PMID: 4056191
A BLIND STUDY.
EPSTEIN E, PINSKI JB. EPSTEIN E, et al. Among authors: pinski jb. Arch Dermatol. 1964 Apr;89:548-9. doi: 10.1001/archderm.1964.01590280048008. Arch Dermatol. 1964. PMID: 14107620 No abstract available.
139 results